共 50 条
Predicting delivery of a small-for-gestational-age infant and adverse perinatal outcome in women with suspected pre-eclampsia
被引:36
|作者:
Griffin, M.
[1
]
Seed, P. T.
[1
]
Duckworth, S.
[1
]
North, R.
[1
]
Myers, J.
[2
]
Mackillop, L.
[3
]
Simpson, N.
[4
]
Waugh, J.
[5
]
Anumba, D.
[6
]
Kenny, L. C.
[7
]
Redman, C. W. G.
[8
]
Shennan, A. H.
[1
]
Chappell, L. C.
[1
]
机构:
[1] Kings Coll London, Womens Hlth Acad Ctr, London SE1 7EH, England
[2] Univ Manchester, Maternal & Fetal Hlth Res Ctr, Manchester, Lancs, England
[3] Oxford Univ Hosp NHS Trust, Oxford, England
[4] Univ Leeds, Fac Hlth, Div Womens & Childrens Hlth, Leeds, W Yorkshire, England
[5] Newcastle Tyne Hosp NHS Fdn Trust, Newcastle, NSW, Australia
[6] Univ Sheffield, Acad Unit Reprod & Dev Med, Sheffield, S Yorkshire, England
[7] Univ Coll Cork, INFANT Irish Ctr Fetal & Neonatal Translat Res, Cork, Ireland
[8] Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford, England
基金:
爱尔兰科学基金会;
美国国家卫生研究院;
关键词:
growth restriction;
placental growth factor;
pre-eclampsia;
small-for-gestational-age;
PLACENTAL GROWTH-FACTOR;
BIRTH-WEIGHT;
DIAGNOSTIC-ACCURACY;
ANGIOGENIC FACTORS;
RESTRICTION;
FETAL;
RISK;
PREGNANCIES;
STILLBIRTH;
SERUM;
D O I:
10.1002/uog.17490
中图分类号:
O42 [声学];
学科分类号:
070206 ;
082403 ;
摘要:
Objective To evaluate the test performance of 47 biomarkers and ultrasound parameters for the prediction of delivery of a small-for-gestational-age (SGA) infant and adverse perinatal outcome in women presenting with suspected pre-eclampsia. Methods This was a prospective, multicenter observational study in which 47 biomarkers and ultrasound parameters were measured in 397 women with a singleton pregnancy presenting with suspected preterm pre-eclampsia between 20+0 and 36+6 weeks' gestation, with the objective of evaluating them as predictors of subsequent delivery of a SGA infant and adverse perinatal outcome. Women with confirmed pre-eclampsia at enrollment were excluded. Factor analysis and stepwise logistic regression were performed in two prespecified groups stratified according to gestational age at enrollment. The primary outcome was delivery of a SGA infant with a birth weight < 3rd customized centile (SGA-3), and secondary outcomes were a SGA infant with a birth weight < 10th customized centile and adverse perinatal outcome. Results In 274 women presenting at 20+0 to 34+6 weeks' gestation, 96 (35%) delivered a SGA-3 infant. For prediction of SGA-3, low maternal placental growth factor (PlGF) concentration had a sensitivity of 93% (95% CI, 84-98%) and negative predictive value (NPV) of 90% (95% CI, 76-97%) compared with a sensitivity of 71% (95% CI, 58-82%) and a NPV of 79% (95% CI, 68-87%) for ultrasound parameters (estimated fetal weight or abdominal circumference < 10th centile). No individual biomarker evaluated had a better performance than did PlGF, and marker combinations made only small improvements to the test performance. Similar results were found in 123 women presenting between 35+0 and 36+6 weeks' gestation. Conclusion In women presenting with suspected preterm pre-eclampsia, measurement of PlGF offers a useful adjunct for identifying those at high risk of delivering a SGA infant, allowing appropriate surveillance and timely intervention. (c) 2017 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of the International Society of Ultrasound in Obstetrics and Gynecology.
引用
收藏
页码:387 / 395
页数:9
相关论文